Home » Clinical trial: CBD use is associated with a reduction in antipsychotics in patients with schizophrenia
Clinical trial: CBD use is associated with a reduction in antipsychotics in patients with schizophrenia
Author Kane Dane Published by
Clinical trial: CBD use is associated with a reduction in antipsychotics in patients with schizophrenia